Pediatric neurosurgeon Lissa Baird, MD, joins Dana-Farber/Boston Children’s

February 11, 2020

Lissa C. Baird, MD

Lissa Baird, MD, has joined Dana-Farber/Boston Children’s Cancer and Blood Disorders Center as director of neurosurgical oncology.

Dr. Baird specializes in the care of children with neurological disorders of the brain and spine, with specific expertise in brain and spinal cord tumors, cerebrovascular malformations, and skull base neurosurgery. She has expertise utilizing neuro-endoscopic and minimally invasive techniques to treat brain tumors, hydrocephalus, and cerebral cysts. She also cares for children with complex spine disorders.

She was previously Chief of Pediatric Neurosurgery and Director of Pediatric Surgical Neuro-Oncology at Oregon Health & Science University/Doernbecher Children's Hospital before returning to Boston to join the Department of Neurosurgery and the Pediatric Brain Tumor Center at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.

Dr. Baird received her medical degree from Columbia University, followed by residency and chief residency at UC San Diego Medical Center. She completed fellowship training in skull base and cerebrovascular neurosurgery at LSU Health Science Center and pediatric neurosurgery at Boston Children’s Hospital/Harvard Medical School.

Dr. Baird is board-certified by the American Board of Neurological Surgery and the American Board of Pediatric Neurological Surgery. Her scientific research has focused on neuro-oncology and clinical outcomes of children with brain tumors. She is an author for several national clinical guidelines for the practice of pediatric neurosurgery, is actively involved in national scientific and leadership committees, and currently serves on the Executive Committee of the Congress of Neurological Surgeons.

In her role at Dana-Farber/Boston Children’s, Dr. Baird will work closely with Katherine E. Warren, MD, clinical director of pediatric neuro-oncology, and Katie Pricola Fehnel, MD, of neurosurgery at Boston Children’s, to expand the research and clinical capabilities of the joint neuro-oncology program.

Media Inquiries

Peter Cohenno
774-218-5530
peter_cohenno@dfci.harvard.edu

Follow Us!

Our Twitter handle is:

Twitter Logo